Literature DB >> 16488155

Oxytocin and estrogen promote rapid formation of functional GABA synapses in the adult supraoptic nucleus.

Dionysia T Theodosis1, Jan-Jurjen Koksma, Andrei Trailin, Sarah L Langle, Richard Piet, Johannes C Lodder, Jaap Timmerman, Huibert Mansvelder, Dominique A Poulain, Stéphane H R Oliet, Arjen B Brussaard.   

Abstract

We here investigated inhibitory synapse turnover in the adult brain using the hypothalamic supraoptic nucleus where new synapses form during different physiological conditions, in particular on oxytocin neurons largely controlled by GABAergic inputs and locally released oxytocin. Patch clamp recordings and ultrastructural analysis of the nucleus in acute slices from late gestating rats showed that oxytocin and estrogen promoted rapid formation of inhibitory synapses. Thus, after 2-h exposure to a combination of oxytocin and 17-beta estradiol, the frequency of miniature inhibitory postsynaptic currents was significantly enhanced. Since their amplitude and presynaptic GABA release probability were unmodified, this indicated an increased number of synapses. Electron microscopy confirmed increased densities of symmetric, putative GABAergic synapses within 2-h exposure to the peptide or steroid, effects which were reversible and oxytocin receptor mediated. Our observations thus offer direct evidence that hypothalamic GABAergic microcircuitries can undergo rapid and functional remodeling under changing neuroendocrine conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16488155     DOI: 10.1016/j.mcn.2006.01.006

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  18 in total

Review 1.  The parental brain and behavior: A target for endocrine disruption.

Authors:  Matthieu Keller; Laura N Vandenberg; Thierry D Charlier
Journal:  Front Neuroendocrinol       Date:  2019-05-18       Impact factor: 8.606

Review 2.  Performance, properties and plasticity of identified oxytocin and vasopressin neurones in vitro.

Authors:  W E Armstrong; L Wang; C Li; R Teruyama
Journal:  J Neuroendocrinol       Date:  2010-02-20       Impact factor: 3.627

Review 3.  Glial regulation of neuronal function: from synapse to systems physiology.

Authors:  J G Tasker; S H R Oliet; J S Bains; C H Brown; J E Stern
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

Review 4.  The BTBR mouse model of idiopathic autism - Current view on mechanisms.

Authors:  K Z Meyza; D C Blanchard
Journal:  Neurosci Biobehav Rev       Date:  2017-02-03       Impact factor: 8.989

Review 5.  Oxytocin release in magnocellular nuclei: neurochemical mediators and functional significance during gestation.

Authors:  Steven L Bealer; William E Armstrong; William R Crowley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-16       Impact factor: 3.619

6.  Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism.

Authors:  Rosanna Sobota; Takuma Mihara; Alexandra Forrest; Robert E Featherstone; Steven J Siegel
Journal:  Behav Neurosci       Date:  2015-08       Impact factor: 1.912

7.  Rapid estradiol-17beta modulation of opioid actions on the electrical and secretory activity of rat oxytocin neurons in vivo.

Authors:  Colin H Brown; Paula J Brunton; John A Russell
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

Review 8.  Polysialic acid and activity-dependent synapse remodeling.

Authors:  Luca Bonfanti; Dionysia T Theodosis
Journal:  Cell Adh Migr       Date:  2009-01-23       Impact factor: 3.405

Review 9.  Functional implications of hypothalamic neurogenesis in the adult mammalian brain.

Authors:  Daniel A Lee; Seth Blackshaw
Journal:  Int J Dev Neurosci       Date:  2012-07-31       Impact factor: 2.457

10.  Prosocial effects of oxytocin in two mouse models of autism spectrum disorders.

Authors:  Brian L Teng; Randal J Nonneman; Kara L Agster; Viktoriya D Nikolova; Tamara T Davis; Natallia V Riddick; Lorinda K Baker; Cort A Pedersen; Michael B Jarstfer; Sheryl S Moy
Journal:  Neuropharmacology       Date:  2013-05-03       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.